From: Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis
Topic | Reference |
---|---|
General aspects of inhalation therapy | [28] |
Dry powder inhalers | |
Tobramycin | [30] |
Colistin | [31] |
Aztreonam lysine for inhalation | |
AIR-CF1 aztreonam three times daily versus placebo | [34] |
AIR-CF2 aztreonam twice daily versus three times daily versus placebo | [35] |
AIR-CF3 follow-up of AIR-CF1 and AIR-CF2 with repeated aztreonam courses | [36] |
Fosfomycin in combination with tobramycin | [45] |